Passage BIO, Inc. - PASG
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | Vestal Point Capital, LP | 0.0% | 0 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Ryan Wilder | 0.0% | 0 | View |
| Jul 02, 2026 | SCHEDULE 13D | — | 20.0% | 3,212,810 | View |
| Jun 25, 2026 | SCHEDULE 13G | Baselake Partners, LP | 7.3% | 235,058 | View |
| Jun 25, 2026 | SCHEDULE 13G | Baselake Management, LLC | 7.3% | 235,058 | View |
| Jun 25, 2026 | SCHEDULE 13G | David Paolella | 7.3% | 235,058 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.